Biochemical Marker for Menkes Disease
Plasma and CSF levels of catechols in 10 patients with Menkes disease, ranging in age from 9 days to 27 months, were compared with control groups and patients with congenital absence of dopamine-B-hydroxylase (DBH) at the National Institutes of Health, Bethesda, MD.
Saved in:
Main Author: | J Gordon Millichap (Author) |
---|---|
Format: | Book |
Published: |
Pediatric Neurology Briefs Publishers,
1993-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetics of Menkes Disease
by: J Gordon Millichap
Published: (1994) -
Menkes Disease: Copper-Histidine Therapy
by: J Gordon Millichap
Published: (1993) -
Neonatal Diagnosis and Treatment of Menkes Disease
by: J Gordon Millichap
Published: (2008) -
Menkes Disease with 'Ragged Red' Fibers
by: J Gordon Millichap
Published: (1989) -
Menkes Maple Syrup Urine Disease: Treatment
by: J Gordon Millichap
Published: (1991)